Propanc Biopharma issues $71,500 convertible note to GS Capital

Propanc Biopharma, Inc.

Principal $71,500 with $4,000 OID; net proceeds $67,500 for general working capital.
Note bears 8% interest; convertible at $0.002/share (fixed) or $0.0009 if stock below $0.0014 for 5 days.
Maturity March 21, 2023; prepayment premiums of 110%-130% depending on timing.
Default conversion price at 65% of lowest trading price over 10 days; default interest 24% per annum.
GS Capital paid $2,500 legal fees; conversion limited to 4.99% beneficial ownership.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.